Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Sei Shu
Expression of C-Terminal ALK, RET, or ROS1 in Lung Cancer Cells With or Without Fusion
BMC Cancer
Cancer Research
Oncology
Genetics
Related publications
Clinicopathological Characteristics and Survival of ALK, ROS1 and RET Rearrangements in Non-Adenocarcinoma Non-Small Cell Lung Cancer Patients
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
OA02.01 Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion-Positive Non-Small Cell Lung Cancer (NSCLC)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Prevalence of ROS1 Fusion in Chinese Patients With Non-Small Cell Lung Cancer
Thoracic Cancer
Medicine
Pulmonary
Respiratory Medicine
Oncology
Outcomes of ALK Positive Lung Cancer Patients Treated With Crizotinib or Second-Generation ALK Inhibitor: A Monoinstitutional Experience
Oncotarget
Oncology
MA16.09 Feasibility, Clinical Relevance of ALK/ROS1 Fusion Variant Detection by Liquid Biopsy in Advanced Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
ALK Fusion Protein Expression in Lung Adenocarcinoma and Its Correlation With EGFR Protein Expression
Madridge Journal of Oncogenesis
Radiotherapy With or Without Concomitant Chemotherapy as Pre- Or Postoperative Therapy in Non-Small Cell Lung Cancer
Journal of Cancer Science & Therapy
P3.cr-13 Dual Drive Coexistence of EML4-ALK Fusion and TPM3-ROS1 Fusion Lung Adenocarcinoma: A Case Report
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Clinical Features of Bim Deletion Polymorphism and Its Relation With Crizotinib Primary Resistance in Chinese Patients With ALK /ROS1 Fusion-Positive Non-Small Cell Lung Cancer
Cancer
Cancer Research
Oncology
